Objectives-The purpose of this study was to assess the diagnostic performance of ultrasound-guided diffuse optical tomography for differentiation of benign and malignant breast lesions.
B
reast cancer is a well-known global health concern and is the most frequent cancer among women worldwide. 1 Assessing lesions early and accurately is vital for the treatment and prognosis of breast cancer. 2 Because of the limitations of biopsy, such as bleeding and discomfort, noninvasive methods are preferred for identifying breast lesions. The sensitivity of mammography for breast cancer screening is good, 3 which has contributed to reducing the mortality of breast cancer. 4 However, the sensitivity of mammography decreases to about 60% in dense breasts. 5 Ultrasound (US) is widely used for further assessment of abnormal mammograms 6 ; however, its specificity is unsatisfactory. [7] [8] [9] Using B-mode US for differentiation of benign and malignant breast lesions, Fischer et al 8 reported sensitivity and specificity of 85% and 60%, respectively, and another study by Thomas et al 9 showed sensitivity of 96% but specificity of only 56%. Therefore, in recent years, studies about noninvasive evaluation of benign and malignant breast lesions have appeared.
Angiogenesis is a main characteristic in the development of cancer, due to an increased blood supply demand, which is the result of fast growth and metabolism. 12, 13 Based on this theory, the altered hemodynamics caused by angiogenesis provided a new way to identify breast lesions.
In 1929, "transillumination" was introduced for diagnosing breast cancer. 14 Limited by the technique of the day and the low resolution of the images, however, its diagnostic performance and clinical usefulness were not satisfactory. In the 1980s, infrared light was used for scanning breast lesions. However, lesion location uncertainty caused by strong light scattering limited its clinical utility. In recent years, diffuse optical tomography has been tried in combination with other imaging techniques such as mammography and US imaging. 11, 15 Due to the good resolution, safety, repeatability, and low cost, US imaging seemed to be the best modality for combination with diffuse optical tomography. Comparing other features of breast diffuse optical tomography, a systematic review of mammography combined with diffuse optical tomography recommended the hemoglobin concentration for identifying breast lesions. 16 As expected, USguided diffuse optical tomography showed considerable performance for diagnosing breast cancer by measuring the total hemoglobin concentration. 17 Previous studies reported that US-guided diffuse optical tomography can differentiate benign and malignant breast lesions. 11, 18 The transducer for US-guided diffuse optical tomography combines a conventional US transducer with an emitter and receiver of near-infrared light ( Figure 1) . 18 It can show both the tissue structure and functional information by using spectral absorption and scattering properties from two optical wavelengths (780 and 830 nm). The optical properties can reflect the hemoglobin concentration, which is a functional feature and is closely correlated with angiogenesis and malignancy. 11, 18 In US-guided diffuse optical tomographic measurements, lesions are located by US, and then the optical imaging proceeds. Both the horizontal and vertical planes of a lesion need to be scanned to obtain integrated optical data. After this process, the same region in the contralateral breast is scanned as a reference. When the necessary data are acquired, the device can draw a region of interest on the lesion automatically based on the US image. The total hemoglobin concentration of a lesion can be detected and quantified according to the optical characteristics. 18 The total hemoglobin concentration is shown in micromoles per liter. Moreover, the device can grade lesions in 5 stages according to the optical characteristics; this scoring method is named the synthesis diagnosis index. The 5 stages have the same meanings as the American College of Radiology Breast Imaging Reporting and Data System, in which stages 1 to 3 indicate benign, and stages 4 and 5 indicate malignant. 19 The detailed theory of diffuse optical tomography had been reported in previous studies. [20] [21] [22] Ultrasound-guided diffuse optical tomography has been reported as a promising technique for identifying breast lesions. 11 However, its diagnostic performance varied in different studies 11, 18 ; moreover, multicenter studies with large samples are absent. Therefore, we conducted this meta-analysis to investigate the diagnostic performance of US-guided diffuse optical tomography for the differentiation of benign and malignant breast lesions.
Materials and Methods

Literature Search
The Cochrane Library, PubMed, and Embase were searched from inception to February 14, 2016, with no language restrictions and using the terms "optical diffusion imaging," "diffuse optical tomography," "ultrasoundguided diffuse optical tomography," "US-guided diffuse optical tomography," "Optimus," "DOT," or "optical tomography imaging ultrasonography" and "breast" or "mammary."
Selection and Exclusion Criteria
Studies were included if they met each of the following criteria: (1) they assessed the performance of US- guided diffuse optical tomography for the differentiation of benign and malignant breast lesions; (2) necessary data were provided to extract true-positive, falsepositive, false-negative, and true-negative results; (3) pathologic examination was the reference standard; and (4) patients were women. Exclusion criteria were as follows: (1) reviews and letters; (2) sample size of less than 30; and (3) duplicate publications. When the same population was reported in several studies, the largest sample size was chosen.
Data Extraction
Two researchers (J.-C.F. and T.W.) independently extracted the following data: the first author and year of publication, country of origin, language used in the article, inclusion period, sample size, proportion of malignant lesions, mean age, number and size of the lesions, instrument used in the study, and diagnostic accuracy. Disagreements between the researchers were resolved by discussion with a third reviewer.
Quality Assessment
Two other researchers (S.T. and B.W.) conducted a quality assessment of the included articles independently. The included studies were evaluated by a revised Quality Assessment of Diagnostic Accuracy Studies tool 23 for assessing the methodological quality of the studies. It comprises 4 aspects: patient selection, index test, reference standard, and flow and timing. For each aspect, various questions to help judge the bias and applicability as low, high, or unclear risk are provided. Flow and timing did not relate to concerns regarding applicability. Differences in the results between the researchers were judged by a third researcher (L.-P.Z.).
Statistical Analysis Stata 12.0 software (StataCorp, College Station, TX) was used in this study. A bivariate mixed-effects binary regression model was used to compute the pooled sensitivity, specificity, likelihood ratio, and diagnostic odds ratio. A summary receiver operating characteristic curve was constructed, and the area under the curve (AUC) was determined.
Clinical and methodological differences may exist when research is pooled in a meta-analysis. The term heterogeneity means differences among included studies, and the degree of heterogeneity reflects the quality of pooled results. 24 To explore the heterogeneity of the included studies, the I 2 statistic of Higgins et al 25 was calculated, and I 2 of greater than 50% indicated significant heterogeneity. 26 If heterogeneity were significant, a meta-regression would be performed to examine whether the sample size (<100 versus 100) or scoring method (total hemoglobin concentration versus synthesis diagnosis index) was the source of the heterogeneity. A sensitivity analysis was conducted to ensure the stability of the pooled results.
Usually, a positive result is more likely to be published than a negative result. This issue may lead to a publication bias. The Deeks funnel plot test was used to judge the publication bias of the included articles, 27 in which the log diagnostic odds ratio against 1= ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi effective sample size p and P < .10 for the slope coefficient would suggest a publication bias.
Results
Search Results and Quality of Studies
Initially, 730 records had been identified by the search strategy from the databases. After all of the titles and abstracts were read, 718 records were excluded because they were unrelated to this topic. Then we read the full text of the 12 remaining studies; of them, 2 studies were duplicate publications; 1 included a sample size of less than 30; 1 had insufficient data; and 2 used the same patient population, for which we extracted the earlier one according to the publication year. Finally, 7 full-text articles were retrieved. 11, 18, 19, [28] [29] [30] [31] Among the 7 articles, 6 were in English, and 1 was in Chinese with an English abstract recorded in Embase. Their characteristics are shown in Tables 1 and 2 . A total of 768 patients with 886 lesions were pooled in this study. All of the lesions were revealed by histopathologic analysis. Of them, 483 lesions (54.5%) were benign, and 403 (45.5%) were malignant. All of the patients in the included studies were enrolled prospectively, and they were examined by the same instrument (Optimus; XinAoMDT Technology Co, Ltd, Hebei, China) except for the study by Zhu et al. 11 The quality assessment results for the included studies are shown in Table 3 .
Diagnostic Accuracy and Heterogeneity Exploration
The sensitivity of the included studies ranged from 79.2% to 100%, and the specificity ranged from 61.4% to 95.9%. A forest plot of pooled sensitivity and specificity with their 95% confidence intervals (CIs) is shown in Figure 2 . The summary sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio were 95% (95% CI, 85%-98%), 77% (95% CI, 66%-85%), 4.07 (95% CI, 2.57-6.45), 0.06 (95% CI, 0.01-0.42), and 57 (95% CI, 12-267), respectively. The summary AUC was 91% (95% CI, 89%-94%; Figure 3 ). No significant heterogeneity was present (I 2 5 7%; 95% CI, 0%-100%). Because significant heterogeneity did not exist, a meta-regression analysis was not performed. In the sensitivity analysis, only minimal changes were observed when we sequentially omitted individual studies. High indicates high risk of bias; low, low risk of bias; and unclear, unclear risk of bias, which means there was insufficient information to permit judgment. 
Publication Bias
The Deeks funnel plot asymmetry test indicated that no publication bias existed (P 5 .32). The corresponding funnel plot is shown in Figure 4 .
Discussion
Ultrasound-guided diffuse optical tomography has developed quickly in recent years, but the results of relevant studies have varied, and their sample sizes have been small. To the best of our knowledge, this study is the first meta-analysis of the diagnostic accuracy of USguided diffuse optical tomography for identifying breast lesions.
In total, 7 studies and 768 patients with 886 lesions were pooled in the analysis. The summary AUC for USguided diffuse optical tomography was 91%. The performance of a diagnostic technique is considered excellent if the AUC is greater than 90% and good if it is greater than 80%. 32 According to this concept, USguided diffuse optical tomography is an excellent technique for differentiation between benign and malignant breast lesions. The results showed high sensitivity (95%), but the specificity was low (77%). In clinical practice, high sensitivity indicates a low rate of missed diagnoses, which contributes to an early diagnosis of breast cancer and a good prognosis. Low specificity indicates a high rate of misdiagnoses, which leads to unnecessary further examinations such as biopsy. However, for cancer, a missed diagnosis is much worse than a misdiagnosis.
Compared with US and elastography, US-guided diffuse optical tomography is able to assess breast lesions in a different way, by showing functional information. Both color Doppler imaging and contrastenhanced US work on the basis of detecting an altered blood supply and angiogenesis for diagnosing breast cancer. According to the published literature, USguided diffuse optical tomography is more accurate than color Doppler imaging, 33, 34 which may be because Doppler US is sensitive only to relatively high-velocity motion of red blood cells in vessels larger than 100 lm in diameter, 35, 36 and some breast cancers may be supplied by vessels smaller than that or may have lowvelocity blood flow. 37 Moreover, vascularization on Doppler US is overlaps considerably with that of benign lesions. 38 Compared with contrast-enhanced US, USguided diffuse optical tomography is easier to perform and less expensive. In addition, its interobserver agreement and reliability have been reported as excellent. 39 A previous study demonstrated that US-guided diffuse optical tomography combined with US could achieve high sensitivity (100%) and pretty high specificity (93.9%). 29 Therefore, the use of US-guided diffuse optical tomography either alone or in combination with other techniques should have good clinical utility.
The results of our quality evaluation showed that 5 of the 7 studies' index tests were considered to have a high risk of bias because those studies used optimal cutoff values instead of a prespecified cutoff value. As we know, optimal cutoff values may raise the sensitivity and specificity factitiously. One study was judged to have high concerns about applicability because the results were interpreted with the knowledge of histologic results, and the cutoff value was not prespecified. Therefore, caution was needed in interpreting our results.
Heterogeneity was not significant among the included studies; therefore, a further investigation for heterogeneity was not conducted. In the sensitivity analysis, we found that the results of this study were stable. In addition, a publication bias did not exist. Therefore, the results of this study were considered credible. The Stata software needs at least 4 studies for analysis. Thus, because of the restriction of the number of included studies, a further subgroup analysis for different clinical characteristics could not be performed.
In both the individual studies and these pooled results, the specificities were relatively low because of a large number of false-positive results. Three of the included studies 11, 18, 30 reported the histopathologic types of 52 false-positive lesions; among these benign lesions, 26 (50%) were fibroadenomas. Zhu et al 11 reported that a higher total hemoglobin concentration in fibroadenomas was caused by a higher density of capillaries. Notably, 2 studies consistently reported that 4 inflammatory lesions had much higher total hemoglobin concentrations than cutoff values. 18, 30 This result may be causes by the promotion of inflammation for angiogenesis. 40, 41 Ultrasound-guided diffuse optical tomography identifies breast lesions by showing the total hemoglobin concentration. An abnormal vascular hemoglobin concentration may influence the accuracy of this method, although in this regard, it has been demonstrated that anemia would not weaken its performance. 30 However, only 27 women with anemia were included in that study. More studies on this issue, especially including women with severe anemia, are warranted. Other drawbacks of US-guided diffuse optical tomography are as follows: For lesions near the nipple, the dark skin has high absorbance, which may affect the results. Small breasts can cause poor transducer-tissue contact, which can cause invalid results. In addition, a unilateral mastectomy will result in the inability to perform US-guided diffuse optical tomography on the contralateral breast.
The main limitation of this study was a heavy dominance of Chinese studies. Due to racial differences in breast cancer, studies from various countries are needed.
In conclusion, this study demonstrated good performance of US-guided diffuse optical tomography for the differentiation of breast lesions. Despite its defects, US-guided diffuse optical tomography is an accurate, effective, noninvasive, and easy technique for identifying breast lesions in daily clinical work. To ensure its clinical usefulness, further studies in different regions are necessary.
